BKA
GNMX
Brick & Kyle Associates’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,000
| Closed | -$2K | – | 395 |
|
|
2017
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 409 |
|
|
2016
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 383 |
|
|
2016
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 376 |
|
|
2016
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 384 |
|
|
2016
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 393 |
|
|
2015
Q4 | $6K | Hold |
1,000
| – | – | 0.01% | 370 |
|
|
2015
Q3 | $8K | Hold |
1,000
| – | – | 0.01% | 367 |
|
|
2015
Q2 | $6K | Hold |
1,000
| – | – | 0.01% | 408 |
|
|
2015
Q1 | $8K | Hold |
1,000
| – | – | 0.01% | 395 |
|
|
2014
Q4 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 396 |
|